Skip to main content

Table 6 Comparison of the diagnostic yield of Undiagnosed Diseases Programs

From: International Undiagnosed Diseases Programs (UDPs): components and outcomes

Undiagnosed diseases program

Enrolled sample

Individuals/families where analysis was completed

Individuals/families with a definite molecular diagnosis (diagnostic yield)

Australia (Victoria) [25]

150 families

150

49 (33%)

Belgium [31]

329 individuals

237

53 (22%)

Canada [25]

1806 families

1806

623 (34%)

Europe [21]

4703 individuals

4411

120 (3%)

Italy [30]

71 individuals

13

3 (23%)

Japan [34]

6301 families

5136

2247 (44%)

Korea [27]

458 individuals

458

242 (53%)

Singapore [24]

275 individuals

196

73 (37%)

South Africa [29]

100 individuals

100

51 (51%)

Spain [28]

147 individuals

30

20 (67%)

Sweden [33]

3219 individuals

3219

1285 (40%)

UK [32]

2183 families

2183

535 (25%)

US [20]

964 individuals

791

231 (29%)

  1. Completed analysis refers to the number of those from the enrolled sample for whom testing was finished (methods of analysis are presented in Fig. 3), and not those for whom testing was ongoing. Diagnostic yield does not include likely diagnoses, or those for which variant validation was pending